NCT00392041View on ClinicalTrials.gov

Eszopiclone in the Treatment of Insomnia and Fibromyalgia

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
FibromyalgiaInsomnia
Interventions
DRUG

Eszopiclone

3mg qpm for 12 weeks

DRUG

placebo

1 pill qpm for 12 weeks

Trial Locations (1)

08854

Department of Psychiatry, UMDNJ-Robert Wood Johnson Medical School, Piscataway

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

Lesley A. Allen, Ph.D.

OTHER

NCT00392041 - Eszopiclone in the Treatment of Insomnia and Fibromyalgia | Biotech Hunter | Biotech Hunter